MoneyWorks4Me

Alembic Pharmaceuticals submits copy of press release

05 Dec 2016 Evaluate

Alembic Pharmaceuticals has submitted a copy of Press Release dated December 05, 2016 titled ‘Alembic Pharmaceuticals receives USFDA Approval for Zolmitriptan Orally Disintegrating Tablets.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..